tiprankstipranks
Trending News
More News >

Study finds GLP-1s may have link to eye disease, STAT reports

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, adding to a short list of concerns about eye health in people taking the powerful medications, STAT’s Elizabeth Cooney reports, citing an observational study in JAMA Ophthalmology. Researchers found that after one year, more than twice as many people on GLP-1 drugs developed neovascular age-related macular degeneration compared to similar people who were not taking the drugs. Manufacturers of GLP-1 medications include Eli Lilly (LLY), Novo Nordisk (NVO), AstraZeneca (AZN), and Sanofi (SNY).

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue